Stewart Goldman Selected Research

Craniospinal Irradiation

1/2021	Benign skull and subdural lesions in patients with prior medulloblastoma therapy.
9/2020	Pediatric Suprasellar Germ Cell Tumors: A Clinical and Radiographic Review of Solitary vs. Bifocal Tumors and Its Therapeutic Implications.
8/2015	Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stewart Goldman Research Topics

Disease

56	Neoplasms (Cancer) 01/2022 - 04/2003
36	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2006
34	Glioma (Gliomas) 11/2023 - 04/2007
20	Medulloblastoma 01/2022 - 01/2006
17	Diffuse Intrinsic Pontine Glioma 12/2022 - 03/2014
10	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 02/2008
9	Ependymoma 01/2019 - 04/2010
8	Central Nervous System Neoplasms 01/2016 - 07/2007
6	Neurofibromatoses (Neurofibromatosis) 01/2021 - 01/2017
5	Brain Stem Neoplasms (Brain Stem Tumor) 01/2022 - 04/2007
5	Plexiform Neurofibroma 01/2021 - 05/2014
5	Fatigue 01/2021 - 07/2007
5	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2020 - 05/2014
5	Hemorrhage 05/2015 - 01/2006
4	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 12/2008
3	Retinoblastoma (Glioblastoma, Retinal) 07/2010 - 03/2008
2	Pain (Aches) 01/2021 - 01/2021
2	Neutropenia 01/2021 - 04/2007
2	Craniopharyngioma (Craniopharyngiomas) 11/2020 - 04/2003
2	Exanthema (Rash) 01/2019 - 08/2017
2	Thrombocytopenia (Thrombopenia) 03/2016 - 02/2015
2	Chronic Disease (Chronic Diseases) 03/2016 - 07/2007
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 08/2015 - 09/2013
2	Nausea 02/2015 - 09/2014
2	Hypoxia (Hypoxemia) 01/2014 - 11/2012
2	Germinoma 09/2013 - 06/2008
2	Sepsis (Septicemia) 07/2010 - 03/2010
2	Disease Progression 07/2010 - 03/2010
2	Gliosarcoma 12/2009 - 05/2009
2	Residual Neoplasm 11/2009 - 12/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2023
1	Teratoma (Teratoid Tumor) 11/2022
1	Cardiotoxicity 01/2022
1	Hypothyroidism 01/2021
1	Leukopenia 01/2021

Drug/Important Bio-Agent (IBA)

18	dipinacoline glutamateIBA 12/2022 - 03/2014
8	Bevacizumab (Avastin)FDA Link 03/2016 - 01/2010
5	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 11/2007
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2011
5	Carboplatin (JM8)FDA LinkGeneric 03/2010 - 03/2008
4	Everolimus FDA Link 11/2023 - 10/2020
4	Histones (Histone)IBA 11/2020 - 05/2014
4	Phosphotransferases (Kinase)IBA 01/2019 - 05/2016
4	Irinotecan (Camptosar)FDA LinkGeneric 02/2018 - 11/2012
4	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 03/2008
4	LuciferasesIBA 04/2012 - 05/2009
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021 - 08/2017
3	AZD 6244IBA 10/2021 - 08/2017
3	Eukaryotic Initiation Factor-4EIBA 01/2018 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 02/2008
3	Peptide Initiation Factors (Initiation Factor)IBA 10/2016 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 11/2012
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014 - 02/2009
3	EnzymesIBA 09/2009 - 04/2007
2	TOR Serine-Threonine KinasesIBA 11/2023 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2016
2	Vorinostat FDA Link 01/2022 - 11/2009
2	VaccinesIBA 01/2022 - 12/2020
2	palbociclibIBA 01/2021 - 11/2016
2	Cyclin-Dependent Kinase 4IBA 01/2021 - 11/2016
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 08/2017
2	Retinoblastoma ProteinIBA 01/2021 - 11/2016
2	MTOR InhibitorsIBA 10/2020 - 09/2014
2	Lenalidomide (CC 5013)FDA Link 09/2020 - 01/2011
2	RE1-silencing transcription factorIBA 01/2019 - 08/2012
2	Protein Isoforms (Isoforms)IBA 01/2019 - 10/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 05/2016 - 09/2014
2	HhAntag691IBA 08/2015 - 11/2013
2	Lapatinib (GW572016)FDA Link 05/2015 - 09/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 09/2014 - 01/2014
2	Sirolimus (Rapamycin)FDA Link 09/2014 - 01/2014
2	CollagenIBA 09/2014 - 01/2006
2	Farnesyltranstransferase (Farnesyltransferase)IBA 05/2014 - 07/2007
2	Vincristine (Oncovin)FDA LinkGeneric 04/2012 - 01/2012
2	O(6)-benzylguanineIBA 02/2012 - 11/2007
2	MicroRNAs (MicroRNA)IBA 01/2011 - 03/2010
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 03/2010 - 12/2008
2	Clofarabine (Clolar)FDA Link 09/2009 - 04/2006
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2009 - 04/2007
1	Ribosomal Protein S6IBA 11/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2023
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2022
1	Antimitotic AgentsIBA 01/2022
1	ribociclibIBA 01/2022
1	mirdametinibIBA 01/2021
1	CytokinesIBA 01/2021
1	cabozantinibIBA 01/2021
1	InterferonsIBA 11/2020

Therapy/Procedure

42	Therapeutics 11/2023 - 10/2005
20	Drug Therapy (Chemotherapy) 01/2022 - 03/2008
12	Radiotherapy 11/2020 - 04/2003
3	Immunotherapy 01/2021 - 01/2019
3	Craniospinal Irradiation 01/2021 - 08/2015
2	Proton Therapy 11/2019 - 04/2015
2	Neoadjuvant Therapy 01/2017 - 08/2015
1	Glycemic Control 04/2023
1	Off-Label Use 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Drug Tapering 01/2021